Patents by Inventor Barry Derham

Barry Derham has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250025535
    Abstract: The present disclosure relates to compositions including suspensions comprising one or more nanosized active pharmaceutical ingredients (APIs) and one or more pharmaceutically acceptable oils, wherein the APIs are selected from proteins and peptides. When the APIs were nanosized and suspended in a pharmaceutically acceptable oil, their release to aqueous environment (i.e., recovery) was hindered compared to the corresponding bulk APIs suspended in the pharmaceutically acceptable oil.
    Type: Application
    Filed: November 17, 2022
    Publication date: January 23, 2025
    Inventors: Panu NOPPARI, Pia RUNEBERG-ROOS, Barry DERHAM, Maria LUME, Satu LAKIO
  • Patent number: 12016922
    Abstract: The present invention provides an aqueous solution comprising an antibody protein at a concentration of at least about 10 mg/mL and an oligomer of ethyleneimine, wherein the number of repeating units of ethyleneimine (n) in the oligomer is in the range of n=2-12.
    Type: Grant
    Filed: November 27, 2019
    Date of Patent: June 25, 2024
    Assignee: Arecor Limited
    Inventors: Jan Jezek, Guy Casy, Barry Derham, Nikki Royle
  • Publication number: 20200138946
    Abstract: The present invention provides an aqueous solution comprising an antibody protein at a concentration of at least about 10 mg/mL and an oligomer of ethyleneimine, wherein the number of repeating units of ethyleneimine (n) in the oligomer is in the range of n=2-12.
    Type: Application
    Filed: November 27, 2019
    Publication date: May 7, 2020
    Inventors: Jan JEZEK, Guy CASY, Barry DERHAM, Nikki ROYLE
  • Publication number: 20150010548
    Abstract: The present invention provides an aqueous solution comprising an antibody protein at a concentration of at least about 10 mg/mL and an oligomer of ethyleneimine, wherein the number of repeating units of ethyleneimine (n) in the oligomer is in the range n=2-12.
    Type: Application
    Filed: January 30, 2013
    Publication date: January 8, 2015
    Applicant: Arecor Limited
    Inventors: Jan Jesek, Guy Casy, Barry Derham, Nikki Royle